Concepedia

Martina Porstner

MP

Statistics

Publications

18

Citations

758

H-Index

13

Active since

2010

Affiliations

Novartis (Germany)(Current)

Medizinische Hochschule Hannover

Heidelberg University

Charité - Universitätsmedizin Berlin

Friedrich-Alexander-Universität Erlangen-Nürnberg

Martina Porstner is an author at Novartis (Germany) specializing in everolimus-based regimens, kidney transplantation, and nephrology.

Publications per year

2010–2022

18

Publications

18

Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study

Klemens Budde, Frank Lehner, Claudia Sommerer et al. · American Journal of Transplantation · 2014 · 127 citations · Full text

, , +17

B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2

Rebecca Winkelmann, Lena Sandrock, Martina Porstner et al. · Proceedings of the National Academy of Sciences · 2010 · 117 citations · Full text

, , +17

miR‐148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2

Martina Porstner, Rebecca Winkelmann, Patrick Daum et al. · European Journal of Immunology · 2015 · 85 citations · Full text

, , +17

miR‐148a is upregulated by Twist1 and T‐bet and promotes Th1‐cell survival by regulating the proapoptotic gene Bim

Claudia Haftmann, Anna‐Barbara Stittrich, Jakob Zimmermann et al. · European Journal of Immunology · 2014 · 64 citations · Full text

, , +17

A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation

Jens Gottlieb, Claus Neurohr, Joachim Müller‐Quernheim et al. · American Journal of Transplantation · 2019 · 57 citations · Full text

, , +17

1–5 of 18